Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sachdev Amit
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   71,325    

Indirect Shares

   7,447      
Direct Value   $26,012,709    

Indirect Value

   $3,501,430      
Total Shares   78,772      
Total Value   $29,514,139      


Vertex Pharmaceuticals Inc $26,012,709 Celladon Corp $0 Vertex Pharmaceuticals Inc $26,012,709 Celladon Corp $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX EVP Chief Patient & Ex... 2024-05-15 55,325 2024-05-15 7,447    Premium*  
            Celladon Corp CLDN 2022-03-11 16,000 2020-03-12 0    Premium*  
* Premium Members only  

Records found :    193         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2019-10-22 4 AS $190.27 $738,818 D/D (3,883) 33,416 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2019-10-25 4 AS $195.01 $840,688 D/D (4,311) 33,416 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2019-11-04 4 AS $199.77 $820,795 D/D (4,097) 33,416 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2019-11-15 4 AS $205.95 $11,739 D/D (57) 33,416 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2019-11-25 4 AS $220.00 $1,100,000 D/D (5,000) 33,416 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2019-12-09 4 AS $225.00 $1,125,000 D/D (5,000) 33,416 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2012-03-30 4 AS $41.01 $1,089,308 D/D (26,562) 33,608 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2011-01-21 4 AS $39.92 $84,950 D/D (2,128) 33,960 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2012-01-19 4 AS $37.00 $150,442 D/D (4,066) 35,008 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-05-04 4 AS $258.59 $11,475,179 D/D (43,752) 35,103 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-05-05 4 AS $265.72 $3,606,232 D/D (13,356) 35,103 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-05-06 4 AS $275.28 $184,162 D/D (669) 35,103 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-05-11 4 AS $276.25 $3,014,014 D/D (10,665) 35,103 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-05-15 4 AS $274.67 $16,496 D/D (58) 35,103 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-08-03 4 AS $276.96 $540,137 D/D (1,941) 35,103 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-11-16 4 AS $222.50 $9,388 D/D (42) 35,103 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-05-06 4 OE $131.89 $88,234 D/D 669 35,772 0 -
VRTX Vertex Pharmaceuticals In... SVP, Global Gov. Strategy   •       –      –    2013-07-11 4 OE $33.28 $232,960 D/D 7,000 35,987 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2011-01-18 4 AS $39.50 $624,685 D/D (15,664) 36,088 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-01-08 4 AS $230.00 $1,150,000 D/D (5,000) 36,190 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-02-03 4 AS $228.89 $946,845 D/D (4,097) 36,190 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-02-24 4 D $239.23 $755,010 D/D (3,156) 36,291 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-08-03 4 OE $86.52 $167,935 D/D 1,941 37,044 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2019-10-22 4 OE $86.52 $335,957 D/D 3,883 37,299 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2019-11-04 4 OE $86.52 $364,235 D/D 4,097 37,513 0 -
  193  Records found
  1   2  3   4   5   6   7   8      
  Page 2 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us